it’s definitely a huge ask... for a company to have figured out how our cells interact with each other... and how that interacts with our immune system... I’m sure man didn’t try to figure out how fire worked before we started using it...
how MsCs function with each disease may be slightly different ... it’s really a moving target.. and something that we should aspire to master at some stage, but to ask a single company to have an answer like that is an almost impossible task.
but if MSCs come good for COVID ARDs, it will be a game changer... a lot more interest and funds will pour into the stem cell industry .. and I hope that becomes the start of the paradigm shift
FDA ODAC Meeting Material discussion analysis, page-348
-
- There are more pages in this discussion • 144 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
0.030(3.06%) |
Mkt cap ! $1.153B | |||
| Open | High | Low | Value | Volume |
| $1.01 | $1.04 | 99.0¢ | $5.111M | 5.050M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 211966 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.02 | 136540 | 9 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |